When was Nutrignomix founded?

Nutrignomix was founded in 2023.

Where is Nutrignomix located?

Nutrignomix is headquartered in Petaling Jaya, Malaysia.

Is Nutrignomix a funded company?

Nutrignomix is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Nutrignomix rank among its competitors?

Nutrignomix ranks 176th amongst 174 active competitors, of which 31 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was OptiBiotix Health, which secured $1.01M in May, 2025.

Who are the top competitors of Nutrignomix?

Nutrignomix's top competitors include Pendulum, The Good Bug and Seed. Among them, OptiBiotix Health secured the most recent funding round in May, 2025.

Nutrignomix - 2026 Company Profile & Competitors

Company Details

Manufacturer of postbiotic supplements for human, animal, and cosmetic applications. The company formulates postbiotic products suitable for health food, health supplements, veterinary products, and cosmetic applications. It focuses on inactivated microbial cells or cell components that contribute to health benefits. The company offers products intended for immune system support, general health, and well-being.

Website: nutrignomix.com
Email ID: *****@nutrignomix.com
Phone Number: +60 **********

Key Metrics

Founded Year

2023

Location

Petaling Jaya, Malaysia

Stage

Unfunded

Ranked

176^th among 199 competitors

Similar Companies

Pendulum & 178 more

View Nutrignomix's full profile

Nutrignomix has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nutrignomix include Pendulum, The Good Bug and Seed. Here is the list of Top 10 competitors of Nutrignomix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pendulum 2012, San Francisco (United States), Series C	Manufacturer of medical probiotics	$111M	Meritech, Sequoia Capital & 13 others	66/100
2nd	The Good Bug 2022, Mumbai (India), Series B	Provider of personalised synbiotic supplements and fermented products for gut health	$20.6M	Fireside Ventures, Sai Global India Fund & 9 others	64/100
3rd	Seed 2016, Los Angeles (United States), Series A	Developer of synbiotics for simulating gut microbiome	$40.6M	Greycroft, BoxGroup & 26 others	57/100
4th	Harmless Harvest 2009, San Francisco (United States), Acquired	Organic coconut water and beverages, ethically sourced and sustainably produced	$30M	Danone Manifesto Ventures, Mousse Partners ... & 1 others	57/100
5th	OptiBiotix Health 2012, York (United Kingdom), Public	Developer of microbial strains for the treatment of human metabolic diseases	-	Seneca EIS Portfolio Fund, Mercia & 2 others	55/100
6th	Oragenics 1996, Tampa (United States), Public	Developer of novel treatments for infectious diseases and oral mucositis as well as probiotics for oral health	-	Third Security, Precigen & 3 others	53/100
7th	The Akkermansia Company 2016, Mont-Saint-Guibert (Belgium), Acquired	Developer of food supplements for human metabolic health issues	-	Nivelinvest, Seventure Partners & 7 others	52/100
8th	One bio 2015, New York City (United States), Series A	Online tools for partner management and opportunity screening.	$27M	Alpha Edison, Morado Ventures & 7 others	50/100
9th	Velbiom Probiotics 2015, Bengaluru (India), Series A	Provider of probiotic supplements for multiple ailments	$5.65M	Tenshi Life Sciences, Strides Pharma Science ... & 20 others	50/100
10th	Probi 1991, Lund (Sweden), Acquired	Developer of probiotic strains and health solutions	-	Eiffel Investment Group	49/100
176th	Nutrignomix 2023, Petaling Jaya (Malaysia), Unfunded	Manufacturer of postbiotic supplements for human, animal, and cosmetic applications	-	-	16/100